Novo Nordisk Proposes Launching More Than 5 Blockbuster Products by 2030 and Expanding Oral GLP-1 Production Capacity
On September 21, Novo Nordisk announced a new round of strategic goals at its Capital Markets Day in...
CSPC Pharmaceutical Group and AstraZeneca Plan to Establish Biologics Joint Venture, with CSPC Holding 51%
On September 18, the State Administration for Market Regulation disclosed that the case concerning t...
AstraZeneca Invests Nearly 200 Million Yuan to Upgrade Its Wuxi, Jiangsu Production Base in China
On September 17, AstraZeneca announced an investment of nearly 200 million yuan to comprehensively u...
Novo Nordisk Partners with Anthropic to Use Claude in Drug R&D
On September 16, Novo Nordisk and AI company Anthropic announced a partnership under which Novo Nord...
China's Innovative Drug Going Global Accelerates Again: Outbound Licensing Exceeds $120 Billion This Year
Since the beginning of this year, the pace of Chinese innovative drugs going global has accelerated ...
South Korea's First Animal Radiopharmaceutical Approved for the Treatment of Feline Hyperthyroidism
The Korea Atomic Energy Research Institute announced on September 10 that "Thyrokitty Injection (I-1...
Merck's Anfu Chang® (Clesrovimab) Launches Commercially in China
On September 9, according to MSD China, Merck's long-acting monoclonal antibody for the prevention o...
ITM and SpiroChem Enter Strategic Collaboration to Advance Novel Radiopharmaceutical Development
Garching/Munich, Germany and Basel, Switzerland, September 8, 2026 – Radiopharmaceutical biotechnolo...
Sinovac Pharma's Apexelsin Obtains Drug Registration Certificate in Uzbekistan
On September 4, Sinovac Pharma announced that its overseas product, Paclitaxel (Albumin-Bound) for I...
QC Ware and IonQ Achieve 0.5 kcal/mol Chemical Accuracy
Quantum software developer QC Ware and ion trap hardware provider IonQ (NYSE: IONQ) have jointly com...
New drugs for key diseases added: What's new in the updated National Essential Medicines List →
The National Essential Medicines List (2026 Edition) took effect today (September 1). The new list b...
FDA Approves Mounjaro to Reduce Cardiovascular Risk in Type 2 Diabetes
The U.S. Food and Drug Administration (FDA) has approved Mounjaro (tirzepatide) to reduce cardiovasc...
Johnson & Johnson's IMAAVY Receives FDA Approval as the World's First Dedicated Therapy for wAIHA
On August 24, Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has appro...
China's innovative drugs accelerate global expansion
Since the start of this year, innovative drugs have emerged as a dark horse on China's export "best-...
FDA Approves Regeneron's Rare Bone Disease Drug Pasatru, Priced Up to $2.1 Million Annually
On August 19, the U.S. Food and Drug Administration (FDA) approved Regeneron Pharmaceuticals' Pasatr...
Trump Nominates Overton to Lead U.S. FDA
On August 19, U.S. President Trump nominated Heidi Overton, Deputy Director of the White House Domes...
WuXi XDC Singapore Site BCM3 Achieves First Overseas GMP Release
WuXi XDC (WuXi XDC Cayman Inc., stock code: 2268.HK) recently announced that the BCM3 dual-function ...
Chugai Grants GSK Exclusive Global License for AID351
On August 17, Chugai Pharmaceutical and GSK signed an exclusive license agreement for the anti-dengu...
Sinovac Biotech's Infliximab Biosimilar Approved in Thailand
On August 18, Reminton®, an infliximab biosimilar introduced by Sinovac Biotech and developed by Mab...
Kunming University of Science and Technology in China Discovers New Antidepressant Target of Qingyangshen Saponins
The team of Professors Xu Tianrui and Xiang Cheng from the Faculty of Life Science and Technology at...
AstraZeneca's Tezspire Officially Launched in China
On August 17, AstraZeneca announced the official launch of Tezspire in China. The product's generic ...
China's Aurisco Pharmaceutical Becomes World's First Generic Oligonucleotide Manufacturer to Pass FDA Inspection
Aurisco Pharmaceutical announced on August 14, 2026, that its facility in Yangzhou, China, has passe...
Bristol Myers Squibb Invests $2.3 Billion to Build Manufacturing Campus in Texas, U.S.
Bristol Myers Squibb (BMS) plans to invest $2.3 billion to build a manufacturing campus spanning app...
US FDA Rejects Novo Nordisk's $16.5B Plant, Korean CDMOs See Opportunity
The U.S. Food and Drug Administration (FDA) has refused to approve a key manufacturing facility owne...
South Korea's Biosolution Signs Cell Therapy Agreement with Hainan Boao International Hospital in China
South Korean biotech company Biosolution is introducing its flagship autologous chondrocyte therapy,...
Eupraxia Pharmaceuticals Reports Q2 2026 Net Loss of $14.5 Million
Eupraxia Pharmaceuticals Inc. reported financial results for the second quarter of 2026 on August 11...
Lupin's Sodium Zirconium Cyclosilicate Receives U.S. FDA Approval with Annual Sales of $568 Million
On August 10, Lupin Limited (Lupin) announced that its Abbreviated New Drug Application for Sodium Z...
Stanford University Uses AI to Design Viral Genomes for the First Time, Synthesizing 16 Phages
Researchers at Stanford University, using generative artificial intelligence tools, have for the fir...
Novo Nordisk to Launch Oral Wegovy Tablets and 7.2 mg Injection Pen in Portugal
Novo Nordisk is set to introduce oral Wegovy tablets to the Portuguese market, available in four dos...
U.S. SCYNEXIS Reports Q2 Results and Initiates Phase 1 Clinical Trial of SCY-770
SCYNEXIS (NASDAQ: SCYX), a clinical-stage biotechnology company, reported its second-quarter financi...